Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004. Medicine and Society Jul 2021 Invisibility of “Gender Dysphoria” Nicolle K. Strand, JD, MBE and Nora L. Jones, PhD Fostering transgender patients’ sense of agency should be a clinical and ethical priority. AMA J Ethics. 2021;23(7):E557-562. doi: 10.1001/amajethics.2021.557. Art of Medicine Jul 2021 Wayfinding Brent R. Carr, MD This charcoal gesture drawing, inspired by a mid-adolescent nonbinary patient, investigates a caregiver’s and patient’s journey from despair to hope. AMA J Ethics. 2021;23(7):E582-583. doi: 10.1001/amajethics.2021.582. Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Dec 2007 Communicable Disease and Immigration Fears Sonal S. Munsiff, MD Virtual Mentor. 2007;9(12):799-805. doi: 10.1001/virtualmentor.2007.9.12.ccas3-0712. In the Literature Dec 2007 Convincing Physicians to Report Communicable Diseases Sarah Lusk Virtual Mentor. 2007;9(12):811-813. doi: 10.1001/virtualmentor.2007.9.12.jdsc1-0712. State of the Art and Science Dec 2007 Diagnosing and Managing Pulmonary Tuberculosis David Pitrak, MD Virtual Mentor. 2007;9(12):814-818. doi: 10.1001/virtualmentor.2007.9.12.cprl1-0712. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Next page Next › Last page Last »
Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004.
Medicine and Society Jul 2021 Invisibility of “Gender Dysphoria” Nicolle K. Strand, JD, MBE and Nora L. Jones, PhD Fostering transgender patients’ sense of agency should be a clinical and ethical priority. AMA J Ethics. 2021;23(7):E557-562. doi: 10.1001/amajethics.2021.557.
Art of Medicine Jul 2021 Wayfinding Brent R. Carr, MD This charcoal gesture drawing, inspired by a mid-adolescent nonbinary patient, investigates a caregiver’s and patient’s journey from despair to hope. AMA J Ethics. 2021;23(7):E582-583. doi: 10.1001/amajethics.2021.582.
Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Dec 2007 Communicable Disease and Immigration Fears Sonal S. Munsiff, MD Virtual Mentor. 2007;9(12):799-805. doi: 10.1001/virtualmentor.2007.9.12.ccas3-0712.
In the Literature Dec 2007 Convincing Physicians to Report Communicable Diseases Sarah Lusk Virtual Mentor. 2007;9(12):811-813. doi: 10.1001/virtualmentor.2007.9.12.jdsc1-0712.
State of the Art and Science Dec 2007 Diagnosing and Managing Pulmonary Tuberculosis David Pitrak, MD Virtual Mentor. 2007;9(12):814-818. doi: 10.1001/virtualmentor.2007.9.12.cprl1-0712.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600.